MarketCap
Puma Biotechnology PBYI
€ 8.77
-7.66%
Facebook
X
Telegram
Puma Biotechnology EV/EBITDA | PBYI
EV/EBITDA Jährlich Puma Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.01 | 4.64 | 8.72 | 8.89 | 24.2 | -23.4 | -11.7 | -12.2 | -8.32 | -3 | -5.47 | -44.4 | -64.7 | -5.25 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.2 | -64.7 | -8.8 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Teva Pharmaceutical Industries Limited
TEVA
|
22.4 | $ 41.75 | -0.12 % | $ 47.8 B |  Israel |
 |
Molecular Templates
MTEM
|
-7.78 | - | -23.43 % | $ 495 K |  USA |
 |
Gossamer Bio
GOSS
|
-2.14 | $ 9.54 | -4.12 % | $ 2.18 B | USA |
 |
Genmab A/S
GMAB
|
2.7 | $ 52.76 | -4.28 % | $ 3.41 B |  Danmark |
 |
GeoVax Labs
GOVX
|
-0.0305 | $ 0.16 | -2.44 % | $ 153 K | USA |
 |
Grifols, S.A.
GRFS
|
13.7 | $ 8.49 | -1.39 % | $ 5.77 B |  Spain |
 |
BioXcel Therapeutics
BTAI
|
-2.54 | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
GlaxoSmithKline plc
GSK
|
32.5 | $ 50.38 | -1.51 % | $ 204 B |  Britain |
 |
CohBar
CWBR
|
-0.0334 | - | -15.44 % | $ 2.2 M | USA |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
0.497 | $ 4.6 | -9.88 % | $ 39.2 M | USA |
 |
NeuBase Therapeutics
NBSE
|
0.988 | - | -1.56 % | $ 12.3 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-5.93 | - | - | $ 2.18 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
-8.74 | - | -6.81 % | $ 3.04 B | USA |
 |
Taysha Gene Therapies
TSHA
|
-11.3 | $ 4.09 | -6.31 % | $ 1.31 B | USA |
 |
Scopus BioPharma
SCPS
|
-0.314 | - | -48.37 % | $ 3.71 M | USA |
 |
Annovis Bio
ANVS
|
-1.23 | $ 0.64 | -46.19 % | $ 13.2 M | USA |
 |
scPharmaceuticals
SCPH
|
-0.286 | - | - | $ 218 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
-0.978 | - | - | $ 105 M | USA |
 |
Athersys
ATHX
|
0.12 | - | 3.77 % | $ 22.4 M | USA |
 |
Global Blood Therapeutics
GBT
|
-6.65 | - | - | $ 4.62 B | USA |
 |
United Therapeutics Corporation
UTHR
|
14.4 | $ 565.49 | -7.07 % | $ 25.1 B | USA |
 |
Inozyme Pharma
INZY
|
-0.428 | - | - | $ 207 M | USA |
 |
Veracyte
VCYT
|
35.1 | $ 23.51 | -55.24 % | $ 1.85 B | USA |
 |
Viking Therapeutics
VKTX
|
-7.87 | $ 25.78 | -7.83 % | $ 2.9 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
-1.86 | - | -23.04 % | $ 26.6 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
-4.89 | $ 3.08 | -10.85 % | $ 32.8 M | USA |
 |
Viridian Therapeutics
VRDN
|
-8.14 | $ 28.53 | -1.81 % | $ 2.91 B | USA |
 |
NanoString Technologies
NSTG
|
-4.54 | - | -37.43 % | $ 5.1 M | USA |
 |
Humanigen
HGEN
|
-0.883 | - | -81.12 % | $ 4.28 M | USA |
 |
Sorrento Therapeutics
SRNE
|
-0.959 | - | -29.58 % | $ 126 M | USA |
 |
Surface Oncology
SURF
|
-0.931 | - | - | $ 59.7 M | USA |
 |
Immunome
IMNM
|
-5.79 | $ 17.86 | -8.5 % | $ 1.56 B | USA |
 |
Immuron Limited
IMRN
|
-43.1 | $ 0.85 | -0.01 % | $ 196 M |  Australia |
 |
Sierra Oncology
SRRA
|
-2.09 | - | -0.05 % | $ 1.34 B |  Canada |
 |
Immunic
IMUX
|
-1.55 | $ 7.44 | -6.3 % | $ 1.16 B | USA |
 |
Incyte Corporation
INCY
|
11.3 | $ 118.15 | -3.83 % | $ 23.1 B | USA |
 |
Cocrystal Pharma
COCP
|
-0.867 | $ 1.0 | -0.99 % | $ 11.3 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
-2.05 | $ 4.2 | -5.83 % | $ 342 M | USA |
 |
Vaccinex
VCNX
|
-0.372 | - | -61.37 % | $ 654 K | USA |
 |
INmune Bio
INMB
|
-0.26 | $ 1.18 | -11.14 % | $ 29.2 M | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
-6.09 | - | -19.68 % | $ 18.4 M | Canada |
 |
Akero Therapeutics
AKRO
|
-10.5 | - | - | $ 3.67 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
-0.771 | $ 3.06 | -5.56 % | $ 129 M | USA |
 |
Xencor
XNCR
|
-6.45 | $ 34.0 | -2.94 % | $ 2.52 B | USA |
 |
Jounce Therapeutics
JNCE
|
1.47 | - | - | $ 98.4 M | USA |
 |
Verona Pharma plc
VRNA
|
-285 | - | - | $ 69.7 B | Britain |
 |
Zai Lab Limited
ZLAB
|
-99.8 | $ 22.61 | -0.83 % | $ 24.8 B |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
-1.5 | $ 1.72 | -2.56 % | $ 124 M | USA |
 |
Corner Growth Acquisition Corp.
COOL
|
-55 | - | -0.89 % | $ 114 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.0567 | - | -24.86 % | $ 820 K | USA |